Nasal compositions comprising alcaftadine
AssigneeAlkem Laboratories Limited
InventorsAkhilesh SHARMA, Babasaheb AWARE, Viraj SHAH, Amol AIWALE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nasal pharmaceutical composition comprising alcaftadine or a pharmaceutically acceptable salt and optionally one or more pharmaceutically acceptable excipients, methods of treating allergic rhinitis, allergic rhino-conjunctivitis, or symptoms thereof (such as nasal congestion) with the nasal pharmaceutical composition, and methods of preparing it.
Claims23
1-24. (canceled)
A method of treating allergic rhinitis in a human patient in need thereof comprising nasally administering to the patient an effective amount of an aqueous pharmaceutical composition comprising about 0.125% to about 0.5% w/w alcaftadine or a pharmaceutically acceptable salt thereof and a mucoadhesive agent.
A method of treating allergic rhinitis in a human patient in need thereof comprising nasally administering once or twice daily to each nostril of the patient about 171.25 to about 685 mcg alcaftadine or a pharmaceutically acceptable salt thereof, wherein the alcaftadine or a pharmaceutically acceptable salt thereof is administered in the form of an aqueous pharmaceutical composition comprising about 0.125% to about 0.5% w/w alcaftadine or a pharmaceutically acceptable salt thereof and a mucoadhesive agent.
Dependencies are inferred from the claim text.